NVO and NOVOB Related Headlines
Go Back- NVO Investors Have Opportunity to Join Novo Nordisk A/S Fraud Investigation with the Schall Law Firm
- Novo To Cut Ozempic, Wegovy's US List Prices By Up To 50% - WSJ
- Novo Nordisk's Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America
- From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes
- Novo Nordisk's CagriSema shows blood pressure reduction in obesity trial
- Novo Nordisk's CagriSema was associated with significant reduction in blood pressure and showed anti-inflammatory effects while reducing the proportion of patients at risk of developing heart disease
- Metsera declares Novo Nordisk's $10 billion bid superior to Pfizer offer
- Metsera Receives Amended Proposal from Novo Nordisk; Metsera Declares Novo Nordisk Amended Proposal "Superior"
- Novo Nordisk makes $9 billion bid for Metsera amid Pfizer deal
- Metsera Receives Unsolicited Proposal from Novo Nordisk
- Pfizer Addresses Proposal for Metsera
- Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis
- Novo Nordisk continues efforts to support patient access to authentic, FDA approved Wegovy® and prioritize patient safety
- Novo Nordisk (NVO) terminates collaboration with Hims & Hers Health (HIMS) due to concerns about their illegal mass compounding and deceptive marketing
- Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing
- GLP-1s Should Be First Line To Prevent Heart Disease, Acc Says - Bloomberg
NVO and NOVOB Related Press Releases
Go Back- NVO Investors Have Opportunity to Join Novo Nordisk A/S Fraud Investigation with the Schall Law Firm
- Novo Nordisk's Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America
- From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes
- Novo Nordisk's CagriSema was associated with significant reduction in blood pressure and showed anti-inflammatory effects while reducing the proportion of patients at risk of developing heart disease
- Metsera Receives Amended Proposal from Novo Nordisk; Metsera Declares Novo Nordisk Amended Proposal "Superior"
- Metsera Receives Unsolicited Proposal from Novo Nordisk
- Pfizer Addresses Proposal for Metsera
- Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis
- Novo Nordisk continues efforts to support patient access to authentic, FDA approved Wegovy® and prioritize patient safety
- Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing
NVO and NOVOB Related SEC Filings
Go Back- Form 6-K NOVO NORDISK A S For: Mar 02
- Form 6-K NOVO NORDISK A S For: Mar 02
- Form 6-K NOVO NORDISK A S For: Feb 23
- Form 6-K NOVO NORDISK A S For: Feb 23
- Form 6-K NOVO NORDISK A S For: Feb 20
- Form 6-K NOVO NORDISK A S For: Feb 16
- Form 6-K NOVO NORDISK A S For: Feb 11
- Form 6-K NOVO NORDISK A S For: Feb 10
- Form 6-K NOVO NORDISK A S For: Feb 09
- Form 6-K NOVO NORDISK A S For: Feb 05
- Form 6-K NOVO NORDISK A S For: Feb 04
- Form 6-K NOVO NORDISK A S For: Feb 04
- Form IRANNOTICE NOVO NORDISK A S
- Form 20-F NOVO NORDISK A S For: Dec 31
- Form 6-K NOVO NORDISK A S For: Dec 31
- Form 6-K NOVO NORDISK A S For: Dec 31
- Form 6-K NOVO NORDISK A S For: Feb 03
- Form 6-K NOVO NORDISK A S For: Feb 02
- Form 6-K NOVO NORDISK A S For: Feb 02
- Form 6-K NOVO NORDISK A S For: Jan 31
- Form 6-K NOVO NORDISK A S For: Dec 22
- Form 6-K NOVO NORDISK A S For: Nov 25
- Form 6-K NOVO NORDISK A S For: Nov 24
- Form 6-K NOVO NORDISK A S For: Nov 17
- Form 6-K NOVO NORDISK A S For: Nov 14
- Form 6-K NOVO NORDISK A S For: Nov 13
- Form 6-K NOVO NORDISK A S For: Nov 11
- Form 6-K NOVO NORDISK A S For: Nov 06
- Form 6-K NOVO NORDISK A S For: Sep 30
- Form 6-K NOVO NORDISK A S For: Oct 30
- Form 6-K NOVO NORDISK A S For: Oct 21
- Form 6-K NOVO NORDISK A S For: Oct 21
- Form 6-K NOVO NORDISK A S For: Oct 09
- Form 6-K NOVO NORDISK A S For: Sep 10
- Form 6-K NOVO NORDISK A S For: Aug 19
- Form 6-K NOVO NORDISK A S For: Aug 15
- Form 6-K NOVO NORDISK A S For: Aug 12
- Form 6-K NOVO NORDISK A S For: Aug 08
- Form 6-K NOVO NORDISK A S For: Aug 07
- Form 6-K NOVO NORDISK A S For: Jun 30
- Form 6-K NOVO NORDISK A S For: Aug 04
- Form 6-K NOVO NORDISK A S For: Jul 29
- Form 6-K NOVO NORDISK A S For: Jul 29
- Form 11-K NOVO NORDISK A S For: Dec 31
- Form 11-K NOVO NORDISK A S For: Dec 31
- Form 6-K NOVO NORDISK A S For: Jun 12

